Blastoid Variant Mantle Cell Lymphoma

• CLINICAL_TRIALS research · 2026-02-19
  Clinical Trial Update: Glofitamab With Obinutuzumab, Venetoclax, and Lenalidomide for the Treatment of Patients With Newly Diagnosed High Risk Mantle Cell Lymphoma [Phase 1, Phase 2]

  A Phase 1/2 clinical trial evaluating a quadruple regimen of glofitamab, obinutuzumab, venetoclax, and lenalidomide for newly diagnosed high…

• CLINICAL_TRIALS trial_result · 2023-01-20
  Clinical Trial Update: Ibrutinib in Treating Patients With Refractory or Relapsed Lymphoma After Donor Stem Cell Transplant [Phase 2]

  Phase 2 trial evaluating ibrutinib in patients with refractory or relapsed lymphoma after donor stem cell transplant completed; results post…